227 related articles for article (PubMed ID: 25899188)
1. Sensitivity Pattern of Second Line Anti-Tuberculosis Drugs against Clinical Isolates of Multidrug Resistant Mycobacterium tuberculosis.
Ghafoor T; Ikram A; Abbasi SA; Zaman G; Ayyub M; Palomino JC; Vandamme P; Martin A
J Coll Physicians Surg Pak; 2015 Apr; 25(4):250-3. PubMed ID: 25899188
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Evaluation of Linezolid and Meropenem Against Clinical Isolates of Multi Drug Resistant Tuberculosis By Mycobacterial Growth Indicator Tube (MGIT) 960.
Mirza IA; Satti L; Khan FA; Khan KA
J Coll Physicians Surg Pak; 2015 Jun; 25(6):427-30. PubMed ID: 26100995
[TBL] [Abstract][Full Text] [Related]
3. Extensively and pre-extensively drug resistant tuberculosis in clinical isolates of multi-drug resistant tuberculosis using classical second line drugs (levofloxacin and amikacin).
Mirza IA; Khan FA; Khan KA; Satti L; Ghafoor T; Fayyaz M
J Coll Physicians Surg Pak; 2015 May; 25(5):337-41. PubMed ID: 26008658
[TBL] [Abstract][Full Text] [Related]
4. Multi-drug resistant tuberculosis in Northern Pakistan.
Butt T; Ahmad RN; Kazmi SY; Rafi N
J Pak Med Assoc; 2004 Sep; 54(9):469-72. PubMed ID: 15518370
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Pyrazinamide Resistance in Khyber Pakhtunkhwa, Pakistan.
Khan MT; Malik SI; Ali S; Sheed Khan A; Nadeem T; Zeb MT; Masood N; Afzal MT
Microb Drug Resist; 2018 Nov; 24(9):1417-1421. PubMed ID: 29584579
[TBL] [Abstract][Full Text] [Related]
6. A population-based study of first and second-line drug-resistant tuberculosis in a high-burden area of the Mexico/United States border.
Becerril-Montes P; Said-Fernández S; Luna-Herrera J; Caballero-Olín G; Enciso-Moreno JA; Martínez-Rodríguez HG; Padilla-Rivas G; Nancy-Garza-Treviño E; Molina-Salinas GM
Mem Inst Oswaldo Cruz; 2013 Apr; 108(2):160-6. PubMed ID: 23579794
[TBL] [Abstract][Full Text] [Related]
7. Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Bakuła Z; Napiórkowska A; Kamiński M; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J; Jagielski T
J Microbiol Immunol Infect; 2016 Jun; 49(3):439-44. PubMed ID: 26117528
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of second-line antituberculosis drug susceptibilities of multidrug-resistant Mycobacterium tuberculosis complex isolates by E-test method].
Şimşek H; Tarhan G; Cesur S
Mikrobiyol Bul; 2015 Jan; 49(1):47-55. PubMed ID: 25706730
[TBL] [Abstract][Full Text] [Related]
9. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.
Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880
[TBL] [Abstract][Full Text] [Related]
10. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates from Pakistan 2010-2014: Implications for disease control.
Jabeen K; Shakoor S; Malik F; Hasan R
Int J Mycobacteriol; 2015 Mar; 4 Suppl 1():47-8. PubMed ID: 27128617
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of extensive drug resistance in multidrug resistance tuberculosis isolates].
Bektöre B; Haznedaroğlu T; Baylan O; Ozyurt M; Ozkütük N; Satana D; Cavuşoğlu C; Seber E
Mikrobiyol Bul; 2013 Jan; 47(1):59-70. PubMed ID: 23390903
[TBL] [Abstract][Full Text] [Related]
12. Primary drug resistance to anti-tuberculosis drugs in major towns of Amhara region, Ethiopia.
Yimer SA; Agonafir M; Derese Y; Sani Y; Bjune GA; Holm-Hansen C
APMIS; 2012 Jun; 120(6):503-9. PubMed ID: 22583363
[TBL] [Abstract][Full Text] [Related]
13. Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in Pakistan.
Javaid A; Hasan R; Zafar A; Chaudry MA; Qayyum S; Qadeer E; Shaheen Z; Agha N; Rizvi N; Afridi MZ; Chima MK; Khan AR; Ghafoor A; Khan S; Awan SR; Akhtar S; Choudry K; Iqbal ZH; Ansarie M; Ahmad N
Int J Tuberc Lung Dis; 2017 Mar; 21(3):303-308. PubMed ID: 28225340
[TBL] [Abstract][Full Text] [Related]
14. A cross-sectional study of tuberculosis drug resistance among previously treated patients in a tertiary hospital in Accra, Ghana: public health implications of standardized regimens.
Forson A; Kwara A; Kudzawu S; Omari M; Otu J; Gehre F; de Jong B; Antonio M
BMC Infect Dis; 2018 Apr; 18(1):149. PubMed ID: 29606091
[TBL] [Abstract][Full Text] [Related]
15. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
Kam KM; Yip CW
Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
[TBL] [Abstract][Full Text] [Related]
16. Drug resistance patterns in pulmonary tuberculosis.
Khoharo HK; Shaikh IA
J Pak Med Assoc; 2011 Mar; 61(3):229-32. PubMed ID: 21465933
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence and risk factors on the resistance related to second-line drugs among multi-drug resistant tuberculosis cases in Shanghai, China].
Li J; Zhang YY; Gui XH; Yuan ZA; Pan QC; Mei J; Shen X
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):796-8. PubMed ID: 22967331
[TBL] [Abstract][Full Text] [Related]
18. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
[TBL] [Abstract][Full Text] [Related]
19. Multi-drug-resistant tuberculosis: the experience of an urban tertiary care hospital in South India using automated BACTEC 460 TB.
Mishra B; Rockey SM; Gupta S; Srinivasa H; Muralidharan S
Trop Doct; 2012 Jan; 42(1):35-7. PubMed ID: 22080484
[TBL] [Abstract][Full Text] [Related]
20. [A survey on resistance to second-line drugs in patients with pulmonary tuberculosis in Shanghai, China].
Shen X; Li J; Gao Q; Xu B; Mei J
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):451-3. PubMed ID: 21781519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
